SPONSOR
Samsung Medical Center
Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 3
Conditions studied: Breast CancerBrain MetastasisAcute Respiratory FailureCardiovascular Diseases (CVD)Cerebro Vascular DiseaseHead and Neck CancerLymphomaBreast Cancer SurvivorshipDigital HealthPremenopausal HR+/HER2- Metastatic Breast Cancer
Samsung Medical Center is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Breast Cancer, Brain Metastasis, Acute Respiratory Failure, Cardiovascular Diseases (CVD).
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Samsung Medical Center
How many clinical trials has Samsung Medical Center sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Samsung Medical Center, of which 11 are actively recruiting participants. These trials cover conditions including Breast Cancer, Brain Metastasis, Acute Respiratory Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Samsung Medical Center research focus on?
Samsung Medical Center clinical trials span Breast Cancer, Brain Metastasis, Acute Respiratory Failure, Cardiovascular Diseases (CVD), Cerebro Vascular Disease, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Samsung Medical Center clinical trial?
To participate in a Samsung Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Samsung Medical Center trials with current recruitment status updated daily.
Clinical Trials by Samsung Medical Center
NCT06330870
Recruiting
Brain Metastasis Development Mechanism in BCBM Patients
Breast Cancer
NCT06479421
Recruiting
A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure
Acute Respiratory Failure
NCT07393412
Recruiting
Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study
Cardiovascular Diseases (CVD)
NCT07190573
Recruiting
Head and Neck Cancer Omics/Integrated Precision Medicine (HOPE)
Head and Neck Cancer
NCT07032103
Recruiting
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Lymphoma
NCT06729684
Recruiting
Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors
Breast Cancer Survivorship
NCT04819243 Phase 2
Recruiting
PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study
Premenopausal HR+/HER2- Metastatic Breast Cancer
NCT07068490
Recruiting
Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.
Coronary Artery Disease
NCT07370623
Recruiting
Development of an AI Assessment System for Pediatric Respiratory Distress : A Prospective Study
Pediatric Respiratory Distress
NCT05896865
Recruiting
Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer
Breast Cancer Stage III
NCT07500701 Phase 3
Recruiting
Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology